Evaluating response to radium-223 using ⁶⁸Ga-PSMA PET/CT imaging in patients with metastatic castration-resistant prostate cancer.

Authors: Shagera, Qaid Ahmed, Gil, Thierry, Barraco, Elisa, Boegner, Petra, Kristanto, Paulus, El Ali, Ziad, Sideris, Spyridon, Martinez Chanza, Nieves, Roumeguère, Thierry, Flamen, Patrick, Artigas, Carlos

Source: Annals of Nuclear Medicine; Feb2025, Vol. 39 Issue 2, p208-216, 9p

Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis

Authors: Rescigno, Pasquale, Dolling, David, Conteduca, Vincenza, Rediti, Mattia, Bianchini, Diletta, Lolli, Cristian, Ong, Michael, Li, Haoran, Omlin, Aurelius G., Schmid, Sabine, Caffo, Orazio, Zivi, Andrea, Pezaro, Carmel J., Morley, Courtney, Olmos, David, Romero-Laorden, Nuria, Castro, Elena, Saez, Maria I., Mehra, Niven, Smeenk, Stella, Sideris, Spyridon, Gil, Thyerry, Banks, Patricia, Sandhu, Shaneen K., Sternberg, Cora N., De Giorgi, Ugo, De Bono, Johann S.

Source: In European Urology Oncology April 2020 3(2):176-182

Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers

Authors: Rescigno, Pasquale, Lorente, David, Dolling, David, Ferraldeschi, Roberta, Rodrigues, Daniel Nava, Riisnaes, Ruth, Miranda, Susana, Bianchini, Diletta, Zafeiriou, Zafeiris, Sideris, Spyridon, Ferreira, Ana, Figueiredo, Ines, Sumanasuriya, Semini, Mateo, Joaquin, Perez-Lopez, Raquel, Sharp, Adam, Tunariu, Nina, de Bono, Johann S.

Source: In European Urology Oncology May 2018 1(1):71-77

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles

Authors: Ruelle, Lucien, Bentea, Georgiana, Sideris, Spyridon, El Koulali, Mohamed, Holbrechts, Stéphane, Lafitte, Jean-Jacques, Grigoriu, Bogdan, Sculier, Claudine, Meert, Anne-Pascale, Durieux, Valérie, Berghmans, Thierry, Sculier, Jean-Paul

Source: In Lung Cancer September 2017 111:150-163

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions

Authors: Sculier, Claudine, Bentea, Georgiana, Ruelle, Lucien, Grigoriu, Bogdan, Coureau, Michelle, Gorham, Julie, Sideris, Spyridon, Holbrechts, Stéphane, Lafitte, Jean-Jacques, Meert, Anne-Pascale, Durieux, Valérie, Berghmans, Thierry, Sculier, Jean-Paul

Source: In Lung Cancer September 2017 111:164-175

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 2: Hematologic, cutaneous and vascular syndromes

Authors: Holbrechts, Stéphane, Gorham, Julie, Sideris, Spyridon, Meert, Anne-Pascale, Durieux, Valérie, Berghmans, Thierry, Sculier, Jean-Paul

Source: In Lung Cancer April 2017 106:93-101

Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer

Authors: Rescigno, Pasquale, Lorente, David, Bianchini, Diletta, Ferraldeschi, Roberta, Kolinsky, Michael P., Sideris, Spyridon, Zafeiriou, Zafeiris, Sumanasuriya, Semini, Smith, Alan D., Mehra, Niven, Jayaram, Anuradha, Perez-Lopez, Raquel, Mateo, Joaquin, Parker, Chris, Dearnaley, David P., Tunariu, Nina, Reid, Alison, Attard, Gerhardt, de Bono, Johann S.

Source: In European Urology November 2016 70(5):724-731

Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With Cabazitaxel.

Authors: Shagera, Qaid Ahmed, Karfis, Ioannis, Sideris, Spyridon, Guiot, Thomas, Woff, Erwin, Martinez-Chanza, Nieves, Roumeguere, Thierry, Gil, Thierry, Flamen, Patrick, Artigas, Carlos

Source: Clinical Nuclear Medicine; Sep2023, Vol. 48 Issue 9, p775-780, 6p

Testicular germ cell tumor: Short and long-term side effects of treatment among survivors.

Authors: GIL, THIERRY¹, SIDERIS, SPYRIDON¹, AOUN, FOUAD² fouad.aoun@bordet.be, VAN VELTHOVEN, ROLAND², SIRTAINE, NICOLAS³, PAESMANS, MARIANNE⁴, AMEYE, LIEVEKE⁴, AWADA, AHMAD¹, DEVRIENDT, DANIEL¹, PELTIER, ALEXANDRE²

Source: Molecular & Clinical Oncology. 2016, Vol. 5 Issue 3, p258-264. 7p. 4 Charts, 3 Graphs.

Subject Terms: *TERATOCARCINOMA, *QUALITY of life, *CANCER relapse, *PULMONARY function tests, *PATERNITY, *THERAPEUTICS

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

Authors: SIDERIS, SPYRIDON¹, AOUN, FOUAD² fouad.aoun@bordet.be, ZANATY, MARC³, MARTINEZ, NIEVES CHANZA⁴, LATIFYAN, SOFIA¹, AWADA, AHMAD¹, GIL, THIERRY¹

Source: Molecular & Clinical Oncology. Jun2016, Vol. 4 Issue 6, p1063-1067. 5p.

Subject Terms: *PACLITAXEL, *BLADDER cancer treatment, *TRANSITIONAL cell carcinoma, *CISPLATIN, *THERAPEUTICS

⁶⁸Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy.

Authors: Shagera, Qaid Ahmed, Artigas, Carlos, Karfis, Ioannis, Critchi, Gabriela, Chanza, Nieves Martinez, Sideris, Spyridon, Peltier, Alexandre, Paesmans, Marianne, Gil, Thierry, Flamen, Patrick

Source: Journal of Nuclear Medicine; Dec2021, Vol. 62 Issue 12, p1-27, 29p

Prevalence and clinical impact of tumor BRCA1 and BRCA2mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer

Authors: Martinez Chanza, Nieves, Bernard, Brandon, Barthelemy, Philippe, Accarain, Anna, Paesmans, Marianne, Desmyter, Laurence, T’Kint de Roodenbeke, Daphne, Gil, Thierry, Sideris, Spyridon, Roumeguere, Thierry, Hamid, Anis A., Sweeney, Christopher J.

Source: Prostate Cancer and Prostatic Diseases; February 2022, Vol. 25 Issue: 2 p199-207, 9p

Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients.

Authors: Plouznikoff, Nicolas, Artigas, Carlos, Sideris, Spyridon, Martinez Chanza, Nieves, Gil, Thierry, Peltier, Alexandre, Flamen, Patrick

Source: Annals of Nuclear Medicine; Dec2019, Vol. 33 Issue 12, p945-954, 10p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Clinical impact of ⁶⁸Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach

Authors: Albisinni, Simone, Artigas, Carlos, Aoun, Fouad, Biaou, Ibrahim, Grosman, Julien, Gil, Thierry, Hawaux, Eric, Limani, Ksenija, Otte, Francois‐Xavier, Peltier, Alexandre, Sideris, Spyridon, Sirtaine, Nicolas, Flamen, Patrick, Velthoven, Roland

Source: BJU International; Aug2017, Vol. 120 Issue 2, p197-203, 7p

Subject Terms: COMPUTED tomography, POSITRON emission tomography, PROSTATE cancer, PROSTATE-specific antigen, LIGANDS (Biochemistry)

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Early Detection of Metastatic Prostate Cancer Relapse on 68Ga-PSMA-11 PET/CT in a Patient Still Exhibiting Biochemical Response.

Authors: Plouznikoff, Nicolas, Artigas, Carlos, Sideris, Spyridon, Gil, Thierry, Flamen, Patrick

Source: Clinical Nuclear Medicine; Jan2020, Vol. 45 Issue 1, p81-82, 2p